Danaher Co. (NYSE:DHR) Shares Sold by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. trimmed its holdings in Danaher Co. (NYSE:DHR) by 4.3% in the fourth quarter, HoldingsChannel.com reports. The firm owned 75,802 shares of the conglomerate’s stock after selling 3,420 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Danaher were worth $17,480,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC acquired a new stake in Danaher during the 4th quarter worth $27,000. Decker Retirement Planning Inc. purchased a new position in shares of Danaher during the fourth quarter worth about $31,000. Teachers Insurance & Annuity Association of America acquired a new stake in shares of Danaher during the third quarter worth about $39,000. MidAtlantic Capital Management Inc. purchased a new stake in shares of Danaher in the 3rd quarter valued at about $40,000. Finally, FSA Wealth Management LLC acquired a new stake in shares of Danaher in the 3rd quarter valued at about $50,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have commented on DHR. UBS Group cut their price target on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research report on Wednesday, October 23rd. Stephens reissued an “overweight” rating and issued a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Wells Fargo & Company decreased their price target on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Finally, Guggenheim assumed coverage on shares of Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 price target on the stock. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Stock Down 1.4 %

Danaher stock opened at $211.92 on Thursday. The firm has a market capitalization of $153.07 billion, a price-to-earnings ratio of 40.14, a price-to-earnings-growth ratio of 2.80 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a fifty-two week low of $210.04 and a fifty-two week high of $281.70. The stock’s fifty day moving average is $234.50 and its two-hundred day moving average is $252.68.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the firm earned $2.09 EPS. Analysts predict that Danaher Co. will post 7.77 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.51%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s payout ratio is 20.45%.

Insider Activity

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 10.90% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.